Disease & Drugs New Drug ApprovalFDA Expands Sevabertinib Approval to First-Line HER2-Mutant NSCLC FDA Expands Sevabertinib Approval to First-Line HER2-Mutant NSCLC Read Post »
Clinical TrialsFate Advances iPSC-Derived CAR T Pipeline With New Lupus Data Fate Advances iPSC-Derived CAR T Pipeline With New Lupus Data Read Post »
Clinical TrialsEvommune Discontinues EVO756 in Atopic Dermatitis After Earlier CSU Setback Evommune Discontinues EVO756 in Atopic Dermatitis After Earlier CSU Setback Read Post »
Disease & Drugs Health TidingsGlyphAllo Shows No Next-Morning Driving Impairment at 375 mg GlyphAllo Shows No Next-Morning Driving Impairment at 375 mg Read Post »
Clinical TrialsCOMP360 Shows 52-Week Benefit in Treatment-Resistant Depression COMP360 Shows 52-Week Benefit in Treatment-Resistant Depression Read Post »
Clinical TrialsDabogratinib Posts Promising 79% Response Rate in Phase 2 Results in Bladde... Dabogratinib Posts Promising 79% Response Rate in Phase 2 Results in Bladde... Read Post »
Clinical TrialsSpyre’s SPY003 Delivers a Strong Phase 2 Signal in Ulcerative Colitis Spyre’s SPY003 Delivers a Strong Phase 2 Signal in Ulcerative Colitis Read Post »
Clinical TrialsDeucrictibant XR Shows 83% Reduction in HAE Attacks Deucrictibant XR Shows 83% Reduction in HAE Attacks Read Post »
Clinical TrialsArlo-cel Shows Strong Results in Hard-to-Treat Multiple Myeloma Arlo-cel Shows Strong Results in Hard-to-Treat Multiple Myeloma Read Post »
Clinical TrialsNovartis’ RNA Therapy Del-desiran Stumbles in Phase 3 DM1 Trial Novartis’ RNA Therapy Del-desiran Stumbles in Phase 3 DM1 Trial Read Post »
Clinical TrialsIMDELLTRA Plus Imfinzi Improves Survival in ES-SCLC IMDELLTRA Plus Imfinzi Improves Survival in ES-SCLC Read Post »
Clinical TrialsMosliciguat Demonstrates Strong Hemodynamic and Functional Efficacy in Phas... Mosliciguat Demonstrates Strong Hemodynamic and Functional Efficacy in Phas... Read Post »
Clinical TrialsCS-101 Base Editing Shows Results in SCD and β-Thalassemia CS-101 Base Editing Shows Results in SCD and β-Thalassemia Read Post »
Clinical TrialsUCB Presents Fenfluramine Data in Rare Epilepsies at EEC 2026 UCB Presents Fenfluramine Data in Rare Epilepsies at EEC 2026 Read Post »
Clinical TrialsResomelagon Shows Clearer Efficacy Signal in Post-Hoc Rheumatoid Arthritis ... Resomelagon Shows Clearer Efficacy Signal in Post-Hoc Rheumatoid Arthritis ... Read Post »
Clinical Trials Disease & Drugs“Rentosertib May Be Testing the Next Big Idea in Aging: Can a Disease Dru... “Rentosertib May Be Testing the Next Big Idea in Aging: Can a Disease Dru... Read Post »
Clinical TrialsSemaglutide Shows Promising BMI Reduction as 40.4% of Children Leave Obesit... Semaglutide Shows Promising BMI Reduction as 40.4% of Children Leave Obesit... Read Post »
Clinical TrialsClover’s RSV Vaccines Show Strong Phase 2 Results in Older Adults Clover’s RSV Vaccines Show Strong Phase 2 Results in Older Adults Read Post »
Clinical TrialsKylo-11 Cuts Lipoprotein(a) by Up to 97% After a Single Dose, Sustaining Ef... Kylo-11 Cuts Lipoprotein(a) by Up to 97% After a Single Dose, Sustaining Ef... Read Post »
ResearchDoes Drinking More Water Really Prevent Kidney Stones? Large Trial Challeng... Does Drinking More Water Really Prevent Kidney Stones? Large Trial Challeng... Read Post »
Drugs Safety AlertEMA Probes Injectable Iron Safety After Reports of Hypophosphataemia and Os... EMA Probes Injectable Iron Safety After Reports of Hypophosphataemia and Os... Read Post »
New Drug ApprovalAstraZeneca Camizestrant Wins FDA Approval in ESR1 Breast Cancer AstraZeneca Camizestrant Wins FDA Approval in ESR1 Breast Cancer Read Post »
Clinical TrialsNovartis’ Pelacarsen Fails Phase III Cardiovascular Outcomes Trial Novartis’ Pelacarsen Fails Phase III Cardiovascular Outcomes Trial Read Post »
Clinical TrialsTislelizumab Plus Chemotherapy Shows Sustained Survival in ESCC Tislelizumab Plus Chemotherapy Shows Sustained Survival in ESCC Read Post »
Clinical TrialsArgo Biopharma’s BW-20805 Cuts HAE Attack Rates by Up to 96% in Phase II ... Argo Biopharma’s BW-20805 Cuts HAE Attack Rates by Up to 96% in Phase II ... Read Post »
Clinical TrialsNEJM Publishes Daraxonrasib Phase 1/2 Data in RAS-Mutant NSCLC NEJM Publishes Daraxonrasib Phase 1/2 Data in RAS-Mutant NSCLC Read Post »
Clinical TrialsRoche’s Vabysmo Sustains Vision Gains and Extends Dosing in Asian PCV Pat... Roche’s Vabysmo Sustains Vision Gains and Extends Dosing in Asian PCV Pat... Read Post »
New Drug ApprovalFDA Approves First Treatment for Alexander Disease, Bringing New Hope to Pa... FDA Approves First Treatment for Alexander Disease, Bringing New Hope to Pa... Read Post »
Clinical TrialsOral Gepotidacin Matches Ceftriaxone in NAAT Analysis of Phase 3 Gonorrhea ... Oral Gepotidacin Matches Ceftriaxone in NAAT Analysis of Phase 3 Gonorrhea ... Read Post »
Clinical TrialsBoehringer Ingelheim Announces Nerandomilast Phase 3 IIM Trial Boehringer Ingelheim Announces Nerandomilast Phase 3 IIM Trial Read Post »
Clinical TrialsClimb Bio CLYM116 Shows Durable APRIL Suppression in IgAN Climb Bio CLYM116 Shows Durable APRIL Suppression in IgAN Read Post »
Clinical TrialsEtentamig Shows Promising Results in Phase 3 CERVINO Trial for Multiple Mye... Etentamig Shows Promising Results in Phase 3 CERVINO Trial for Multiple Mye... Read Post »
Clinical TrialsIvonescimab Shows Overall Survival Benefit in Phase III HARMONi-2 NSCLC Tri... Ivonescimab Shows Overall Survival Benefit in Phase III HARMONi-2 NSCLC Tri... Read Post »
Clinical TrialsApazunersen Fails Phase 3 Aspire Trial in Angelman Syndrome Apazunersen Fails Phase 3 Aspire Trial in Angelman Syndrome Read Post »
Clinical TrialsIfebemtinib Plus Garsorasib Shows Promising Activity in KRAS G12C-Mutant Me... Ifebemtinib Plus Garsorasib Shows Promising Activity in KRAS G12C-Mutant Me... Read Post »
Clinical TrialsCamrelizumab-Rivoceranib Improves Survival Across Age Groups in Unresectabl... Camrelizumab-Rivoceranib Improves Survival Across Age Groups in Unresectabl... Read Post »
Clinical TrialsTeva’s TEV ‘408 Shows Positive Phase 2a Celiac Disease Results Teva’s TEV ‘408 Shows Positive Phase 2a Celiac Disease Results Read Post »
Drugs Safety AlertFDA Adds Boxed Warning to Injectafer Over Serious Hypophosphatemia Risk FDA Adds Boxed Warning to Injectafer Over Serious Hypophosphatemia Risk Read Post »
Clinical TrialsPlixorafenib Shows Positive Interim Results in BRAF Fusion Tumors Plixorafenib Shows Positive Interim Results in BRAF Fusion Tumors Read Post »
Clinical TrialsRezatapopt Shows Promising 46% Response Rate in Ovarian Cancer Rezatapopt Shows Promising 46% Response Rate in Ovarian Cancer Read Post »
New Drug ApprovalEnhertu Plus Pertuzumab Wins EU Approval After Strong Phase III Results Enhertu Plus Pertuzumab Wins EU Approval After Strong Phase III Results Read Post »
Clinical TrialsNovartis Remibrutinib Shows Strong Phase 3 Results in Multiple Sclerosis Novartis Remibrutinib Shows Strong Phase 3 Results in Multiple Sclerosis Read Post »
Clinical TrialsTagrisso Plus Orpathys Improves Progression-Free Survival in First-Line MET... Tagrisso Plus Orpathys Improves Progression-Free Survival in First-Line MET... Read Post »
Clinical TrialsNirmatrelvir–Ritonavir Fails to Improve Long COVID in Large Phase 2 RECOV... Nirmatrelvir–Ritonavir Fails to Improve Long COVID in Large Phase 2 RECOV... Read Post »
Clinical TrialsArrowhead’s Plozasiran Cuts Triglycerides Up to 81% and Reduces Pancreati... Arrowhead’s Plozasiran Cuts Triglycerides Up to 81% and Reduces Pancreati... Read Post »
Clinical TrialsSRD-002 Delivers Sustained 12-Month Improvements in HFpEF SRD-002 Delivers Sustained 12-Month Improvements in HFpEF Read Post »
Clinical TrialsZanidatamab Plus Chemotherapy Improves Survival in HER2+ GEA Zanidatamab Plus Chemotherapy Improves Survival in HER2+ GEA Read Post »
Clinical TrialsTaltz and Zepbound Sustain One-Year Benefits in Psoriatic Disease with Obes... Taltz and Zepbound Sustain One-Year Benefits in Psoriatic Disease with Obes... Read Post »
New Drug ApprovalFirst New ET Treatment in Nearly 30 Years: BESREMi Wins FDA Approval First New ET Treatment in Nearly 30 Years: BESREMi Wins FDA Approval Read Post »
Clinical TrialsRepatha Cuts Death Risk in High-Risk Patients Before a First Heart Attack o... Repatha Cuts Death Risk in High-Risk Patients Before a First Heart Attack o... Read Post »
